Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
The current price of LFCR is $4.68 USD — it has decreased by -5.45% in the past 24 hours. Watch Lifecore Biomedical stock price performance more closely on the chart.
What is Lifecore Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lifecore Biomedical stocks are traded under the ticker LFCR.
Is Lifecore Biomedical stock price growing?▼
LFCR stock has fallen by -1.47% compared to the previous week, the month change is a -15.52% fall, over the last year Lifecore Biomedical has showed a -37.52% decrease.
What is Lifecore Biomedical market cap?▼
Today Lifecore Biomedical has the market capitalization of 175.54M
When is the next Lifecore Biomedical earnings date?▼
Lifecore Biomedical is going to release the next earnings report on July 31, 2026.
What were Lifecore Biomedical earnings last quarter?▼
LFCR earnings for the last quarter are -0.43 USD per share, whereas the estimation was -0.29 USD resulting in a -48.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lifecore Biomedical revenue for the last year?▼
Lifecore Biomedical revenue for the last year amounts to 106.63M USD.
What is Lifecore Biomedical net income for the last year?▼
LFCR net income for the last year is -31.04M USD.
How many employees does Lifecore Biomedical have?▼
As of July 18, 2026, the company has 382 employees.
In which sector is Lifecore Biomedical located?▼
Lifecore Biomedical operates in the Health & Wellness sector.
When did Lifecore Biomedical complete a stock split?▼
Lifecore Biomedical has not had any recent stock splits.
Where is Lifecore Biomedical headquartered?▼
Lifecore Biomedical is headquartered in Chaska, United States.